Pediatric Eosinophilic Esophagitis: Results of the European Retrospective Pediatric Eosinophilic Esophagitis Registry (RetroPEER)
Overview
Authors
Affiliations
Objectives: Recommendations for diagnosing and treating eosinophilic esophagitis (EoE) are evolving; however, information on real world clinical practice is lacking. To assess the practices of pediatric gastroenterologists diagnosing and treating EoE and to identify the triggering allergens in European children.
Methods: Retrospective anonymized data were collected from 26 European pediatric gastroenterology centers in 13 countries. Inclusion criteria were: Patients diagnosis with EoE, completed investigations prescribed by the treating physician, and were on stable medical or dietary interventions.
Results: In total, 410 patients diagnosed between December 1999 and June 2016 were analyzed, 76.3% boys. The time from symptoms to diagnosis was 12 ± 33.5 months and age at diagnosis was 8.9 ± 4.75 years. The most frequent indications for endoscopy were: dysphagia (38%), gastroesophageal reflux (31.2%), bolus impaction (24.4%), and failure to thrive (10.5%). Approximately 70.3% had failed proton pump inhibitor treatment. The foods found to be causative of EoE by elimination and rechallenge were milk (42%), egg (21.5%), wheat/gluten (10.9%), and peanut (9.9%). Elimination diets were used exclusively in 154 of 410 (37.5%), topical steroids without elimination diets in 52 of 410 (12.6%), both diet and steroids in 183 of 410 (44.6%), systemic steroids in 22 of 410 (5.3%), and esophageal dilation in 7 of 410 (1.7%). Patient refusal, shortage of endoscopy time, and reluctance to perform multiple endoscopies per patient were noted as factors justifying deviation from guidelines.
Conclusions: In this "real world" pediatric European cohort, milk and egg were the most common allergens triggering EoE. Although high-dose proton pump inhibitor trials have increased, attempted PPI treatment is not universal.
Lutzu N, Favale A, Demurtas M, Del Giacco S, Onali S, Fantini M Front Med (Lausanne). 2025; 11:1513417.
PMID: 39906352 PMC: 11790572. DOI: 10.3389/fmed.2024.1513417.
Chehade M, Hiremath G, Zevit N, Oliva S, Pela T, Khodzhayev A Gastro Hep Adv. 2024; 3(8):1054-1068.
PMID: 39529644 PMC: 11550740. DOI: 10.1016/j.gastha.2024.08.009.
Schlager H, Baumann-Durchschein F, Steidl K, Hafner M, Dinkhauser P, Weitersberger M Wien Klin Wochenschr. 2024; 136(Suppl 10):479-499.
PMID: 39230674 PMC: 11387459. DOI: 10.1007/s00508-024-02401-w.
Navarro P, Feo-Ortega S, Casabona-Frances S, Gutierrez-Junquera C, Savarino E, Amorena E Eur J Pediatr. 2024; 183(8):3567-3578.
PMID: 38819501 PMC: 11263422. DOI: 10.1007/s00431-024-05618-z.
Chan J, Flynn D, Gordon M, Parmar R, Moolenschot K, Jackman L BMJ Paediatr Open. 2024; 8(1).
PMID: 38782481 PMC: 11116858. DOI: 10.1136/bmjpo-2023-002467.